Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJ5JW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,188
Award facts
- Contract value 100% obligated
- $11,187.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Calquence 100 mg tablets (60-count) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of October 20, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Calquence is an oncology medication used in the treatment of hematologic malignancies, reflecting AmerisourceBergen Drug Corp's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill specialized medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. This delivery order supports the Defense Health Agency and other government healthcare systems through DLA's pharmaceutical supply chain, which is integral to maintaining medical readiness and healthcare delivery across the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FJ5JW?
SPE2DB25FJ5JW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJ5JW worth?
The government has obligated $11,188 on SPE2DB25FJ5JW.
Is contract SPE2DB25FJ5JW an order under another contract?
Yes. SPE2DB25FJ5JW is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5JW competed?
The extent of competition for SPE2DB25FJ5JW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award